Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: How much do we know?

Journal of Infectious Diseases

Volumn 201, Issue SUPPL. 2, 2010, Pages

  Gottlieb, Sami L ^a   Berman, Stuart M ^a   Low, Nicola ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; ECTOPIC PREGNANCY; FEMALE INFERTILITY; GENITAL TRACT INFECTION; INFECTION PREVENTION; MORBIDITY; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; UTERINE TUBE DISEASE; COHORT ANALYSIS; FEMALE; GYNECOLOGIC DISEASE; HUMAN; MASS SCREENING; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77953092687     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652396     Document Type: Review

References (39)

1. Centers for Disease Control and Prevention. Infertility Prevention Program, USA. http://www.cdc.gov/std/infertility/ipp.htm. Accessed 29 January 2009.
2. Low N; SCREen project team. Publication of report on chlamydia control activities in Europe. Euro Surveill 2008; 13(28).pii:18924; erratum: Euro Surveill 2008;13(34).pii:18960,
3. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010;201 (suppl 2):S134-S155 (in this supplement).
4. Stamm WE. Chlamydia trachomatis infections in the adult. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. New York: McGraw Hill Medical, 2008:575-594.
5. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 2006; 55.
6. Geisler WM. Duration of untreated, uncomplicated genital Chlamydia trachomatis infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010;201(suppl 2):S104-S113 (in this supplement).
7. Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5year follow-up study. J Infect Dis 2005; 191(6):907-916.
8. Morré SA, van den Brule AJ, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002; 13 (suppl 2): 12-18.
9. Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. MMWR Morb Mortal Wkly Rep 2009;58(14): 362-365.
10. Low N, Bender N, Nartey L, Shang A, Stephenson JM.. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol 2009; 38(2): 435-448.
11. Østergaard L, Andersen B, Moller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a duster-randomized 1-year follow-up study. Clin Infect Dis 2000;31(4):951-957.
12. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334(21):1362-1366. (Pubitemid 26152715)
13. Clark KL, Howell MR, Li Y, et al. Hospitalization rates in female US Army recruits associated with a screening program for Chlamydia trachomatis. Sex Transm Dis 2002;29(1):1-5. (Pubitemid 34074424)
14. Andersen B, Østergaard L, Puho E, Skriver MV, Schonheyder HC. Ectopic pregnancies and reproductive capacity after Chlamydia trachomatis positive and negative test results: a historical follow-up study. Sex Transm Dis 2005;32(6):377-381.
15. Bakken IJ, Skjeldestad FE, Lydersen S, Nordbo SA. Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sex Transm Dis 2007;34(10):739-743.
16. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent, chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176:103-107.
17. Low N, Egger M, Sterne JA, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect 2006;82(3):212-218. (Pubitemid 43901588)
18. Hillis SD, Nakashima A, Amsterdam L, et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect 1995;27(3):108-111.
19. Kamwendo F, Forslin L, Bodin L, Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease: a 25-year study from an urban area of central Sweden. Sex Transm Dis 1996;23(5):384-391. (Pubitemid 26313847)
20. Chen MY, Pan Y, Britt H, Donovan B. Trends in clinical encounters for pelvic inflammatory disease and epididymitis in a national sample of Australian general practices. Int J STD AIDS 2006;17(6):384-386. (Pubitemid 43765399)
21. Egger M., Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998;316(7147):1776-1780. (Pubitemid 28269151)
22. Meyers DS, Halvorson H, Luckhaupt S. Screening for chlamydial infection: an evidence update for the US Preventive Services Task Force. Ann Intern. Med 2007; 147(2):135-142. (Pubitemid 351664618)
23. Paavonen J, Weström L, Eschenbach DA. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually transmitted diseases. New York: McGraw Hill Medical, 2008:1017-1050.
24. Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005;32(12):778-784.
25. Burstein GR, Zenilman JM, Gaydos CA, et al. Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Infect 2001;77(1):26-32.
26. Niccolai LM, Hochberg AL, Ethier KA, Lewis JB, Ickovics JR. Burden of recurrent Chlamydia trachomatis infections in young women: further uncovering the "hidden epidemic." Arch Pediatr Adolesc Med 2007; 161(3):246-251.
27. Brunham RC, Rekart ML. Considerations on Chlamydia trachomatis disease expression. FEMS Immunol Med Microbiol 2009;55(2): 162-166.
28. Peterman TA, Gottlieb SL, Berman SM. Commentary: Chlamydia trachomatis screening: what are we trying to do? Int J Epidemiol 2009; 38(2):449-451.
29. Hu D, Hook EW, III, Goldie SJ. The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis 2006;33(7):428-436.
30. van Valkengoed I, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes-implications for cost-effectiveness analyses. Int J Epidemiol 2004;33(2):416-425.
31. Oakeshott P, Kerry S, Atherton H, et al. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pdvic infection) trial. Trials 2008; 9: 73.
32. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340: c1642.
33. van den Broek IV, Hoebe CJ, van Bergen JE, et al. Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis. BMC Infect Dis 2010; 10:89.
34. Batteiger BE, Tu W, Ofner S, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010;201:42-51.
35. Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI, Hook EW III. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008;35(2): 119-123.
36. Simms I, Warburton F, Westrom L. Diagnosis of pdvic inflammatory disease: time for a rethink. Sex Transm Infect 2003;79(6):491-1194 (Pubitemid 38021412)
37. Hafner LM, McNeilly C. Vaccines for Chlamydia infections of the female genital tract. Future Microbiol 2008; 3(1):67-77.
38. Byrne GI. Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J Infect Dis 2010; 201 (suppl 2):S126-S133 (in this supplement).
39. Darville T, Hiltke T. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 2010;201(suppl 2):S114-S125 (in this supplement).